Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.57
-0.09 (-1.59%)
At close: Jun 6, 2025, 4:00 PM
5.55
-0.02 (-0.36%)
After-hours: Jun 6, 2025, 4:04 PM EDT
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $167.52 million as of June 6, 2025. Its market cap has decreased by -15.69% in one year.
Market Cap
167.52M
Enterprise Value
123.89M
1-Year Change
-15.69%
Ranking
Category
Stock Price
$5.57
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $167.52M, an increase of 47.47%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 167.40M | -9.61% |
| Dec 31, 2024 | 185.20M | 2.09% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |